Table 2.
Reimbursement by drug programme type in years 2015-2018 in Poland [USD].
| Year | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| DRUG PROGRAMMES | Value [USD] | 635,434,206 | 755,656,672 | 854,272,086 | 921,165,770 |
| Number | 69 | 73 | 83 | 92 | |
| Oncological Drug Programmes | Value [USD] | 305,367,160 | 321,264,182 | 402,520,374 | 483,023,398 |
| Share [%] | 48.1 | 42.5 | 47.1 | 52.4 | |
| Number | 49 | 52 | 29 | 32 | |
| Nononcological Drug Programmes | Value [USD] | 330,067,046 | 434,392,490 | 451,751,712 | 438,142,372 |
| Share [%] | 51.9 | 57.5 | 52.9 | 47.6 | |
| Number | 20 | 21 | 64 | 60 | |
Source: the authors based on NHF data.
Bolded volumes are the most important data in Table 2 .